Literature DB >> 31633384

Twenty-Four Hour Fasting (Basal Rate) Tests to Achieve Custom-Tailored, Hour-by-Hour Basal Insulin Infusion Rates in Patients With Type 1 Diabetes Using Insulin Pumps (CSII).

Michael A Nauck1,2, Anna M Lindmeyer2, Chantal Mathieu3, Juris J Meier2.   

Abstract

BACKGROUND: Twenty-four hour fasting periods are being used to scrutinize basal insulin infusion rates for pump-treated patients with type 1 diabetes.
METHODS: Data from 339 consecutive in-patients with adult type 1 diabetes on insulin pump therapy undergoing a 24-hour fast as a basal rate test were retrospectively analyzed. Hourly programmed basal insulin infusion rates and plasma glucose concentrations within, below, or above arbitrarily defined target ranges were assessed for periods of the day of special interest (eg, 01:00-07:00 am, "dawn" period, 04:00-07:00 pm, and "dusk" period). Statistics: χ2-tests, paired t-tests were used.
RESULTS: Basal rates (mean: 0.90 ± 0.02 IU/h) showed circadian variations with peaks corresponding to "dawn" (1.07 ± 0.02 IU/h from 01:00 to 07:00 am) and, less prominently, "dusk" (0.95 ± 0.02 IU/h from 03:00 to 07:00 pm). Individual mean plasma glucose concentrations averaged 6.6 ± 0.1 mmol/L, with 53.1% in the predefined "strict" (4.4-7.2 mmol/L) target range. Interestingly, during the "dawn" period, plasma glucose was significantly higher (by 0.5 ± 0.1 mmol/L [95% confidence interval: 0.3-0.8 mmol/L; P < .0001]) and the odds ratio for hypoglycemia was significantly lower compared to the reference period.
INTERPRETATION: Twenty-four hour fasting periods as basal rate tests frequently unravel periods with inappropriate basal insulin infusion rates potentially responsible for fasting hyper- or hypoglycemia. Notably, the higher basal insulin infusion rate found during the "dawn" period seems to be justified and may need to be accentuated.

Entities:  

Keywords:  basal rate profiles; dawn phenomenon; dusk phenomenon; insulin pump (CSII: continuous subcutaneous insulin infusion); type 1 diabetes

Year:  2019        PMID: 31633384      PMCID: PMC8256064          DOI: 10.1177/1932296819882752

Source DB:  PubMed          Journal:  J Diabetes Sci Technol        ISSN: 1932-2968


  22 in total

Review 1.  Insulin-pump therapy for type 1 diabetes mellitus.

Authors:  John C Pickup
Journal:  N Engl J Med       Date:  2012-04-26       Impact factor: 91.245

Review 2.  6. Glycemic Targets: Standards of Medical Care in Diabetes-2019.

Authors: 
Journal:  Diabetes Care       Date:  2019-01       Impact factor: 19.112

3.  Characteristics of basal insulin requirements by age and gender in Type-1 diabetes patients using insulin pump therapy.

Authors:  Gary Scheiner; Bret A Boyer
Journal:  Diabetes Res Clin Pract       Date:  2004-12-22       Impact factor: 5.602

4.  Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.

Authors:  J Hermanides; K Nørgaard; D Bruttomesso; C Mathieu; A Frid; C M Dayan; P Diem; C Fermon; I M E Wentholt; J B L Hoekstra; J H DeVries
Journal:  Diabet Med       Date:  2011-10       Impact factor: 4.359

5.  The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

Authors:  D M Nathan; S Genuth; J Lachin; P Cleary; O Crofford; M Davis; L Rand; C Siebert
Journal:  N Engl J Med       Date:  1993-09-30       Impact factor: 91.245

6.  Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial.

Authors:  Trang T Ly; Jennifer A Nicholas; Adam Retterath; Ee Mun Lim; Elizabeth A Davis; Timothy W Jones
Journal:  JAMA       Date:  2013-09-25       Impact factor: 56.272

7.  Pathogenesis of the dawn phenomenon in patients with insulin-dependent diabetes mellitus. Accelerated glucose production and impaired glucose utilization due to nocturnal surges in growth hormone secretion.

Authors:  P J Campbell; G B Bolli; P E Cryer; J E Gerich
Journal:  N Engl J Med       Date:  1985-06-06       Impact factor: 91.245

Review 8.  Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis.

Authors:  Kirstine J Bell; Alan W Barclay; Peter Petocz; Stephen Colagiuri; Jennie C Brand-Miller
Journal:  Lancet Diabetes Endocrinol       Date:  2013-10-25       Impact factor: 32.069

9.  Spontaneous and transient predinner hyperglycemia in some patients with diabetes: Dusk phenomenon.

Authors:  Wei Li; Si-Na Du; Min-Jia Shi; Zhan-Zhan Sun
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

10.  Thirty years of research on the dawn phenomenon: lessons to optimize blood glucose control in diabetes.

Authors:  Francesca Porcellati; Paola Lucidi; Geremia B Bolli; Carmine G Fanelli
Journal:  Diabetes Care       Date:  2013-12       Impact factor: 19.112

View more
  3 in total

1.  Patients with Type 1 Diabetes Treated with Insulin Pumps Need Widely Heterogeneous Basal Rate Profiles Ranging from Negligible to Pronounced Diurnal Variability.

Authors:  Anna M Lindmeyer; Juris J Meier; Michael A Nauck
Journal:  J Diabetes Sci Technol       Date:  2020-08-18

2.  Prediction of Individual Basal Rate Profiles From Patient Characteristics in Type 1 Diabetes on Insulin Pump Therapy.

Authors:  Michael A Nauck; Melanie Kahle-Stephan; Anna M Lindmeyer; Sina Wenzel; Juris J Meier
Journal:  J Diabetes Sci Technol       Date:  2020-11-30

3.  A Pilot Study of Flat and Circadian Insulin Infusion Rates in Continuous Subcutaneous Insulin Infusion (CSII) in Adults with Type 1 Diabetes (FIRST1D).

Authors:  Siân Rilstone; Monika Reddy; Nick Oliver
Journal:  J Diabetes Sci Technol       Date:  2020-02-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.